Chemically-Boosted Corneal Cross-Linking for the Treatment of Keratoconus through a Riboflavin 0.25% Optimized Solution with High Superoxide Anion Release

The purpose of this study was to evaluate the effectiveness and safety of a novel buffered riboflavin solution approved for corneal cross-linking (CXL) in progressive keratoconus and secondary corneal ectasia. Following the in vivo preclinical study performed on New Zealand rabbits comparing the nov...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazzotta, Cosimo, Ferrise, Marco, Gabriele, Guido, Gennaro, Paolo, Meduri, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004796/
https://www.ncbi.nlm.nih.gov/pubmed/33806928
http://dx.doi.org/10.3390/jcm10061324

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8004796/
https://www.ncbi.nlm.nih.gov/pubmed/33806928
http://dx.doi.org/10.3390/jcm10061324

Ejemplares similares